Infusion-Pump Treatment of Diabetes Mellitus

John Pickup; Giancarlo Viberti; Harry Keen; John Parsons; George Alberti; F. J. Service; R. A. Rizza; J. E. Gerich; Robert B. Tattersall; Edwin A.M. Gale; Philip Felig; William Tamborlane; Robert S. Sherwin; Myron Genel

doi:10.1056/NEJM197908023010511

Infusion-Pump Treatment of Diabetes Mellitus

John Pickup, Giancarlo Viberti, Harry Keen, John Parsons, George Alberti, F. J. Service, R. A. Rizza, J. E. Gerich, Robert B. Tattersall, Edwin A.M. Gale, Philip Felig, William Tamborlane, Robert S. Sherwin, Myron Genel

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Abstract

To the Editor: The report by Dr. Tamborlane and his colleagues¹ confirmed our preliminary results² ³ ⁴ on short-term, continuous, subcutaneous insulin infusion (CSII) in insulin-dependent diabetics. The portable Auto Syringe that they used clearly has a more flexible rate adjustment than our earlier model had, but this versatility can only be bought at a price that we considered excessive. The drawbacks are the weight and bulk of the device and, of equal importance, the liability to ill advised tinkering and tampering with infusion rates. Simplicity and reliability seem to us to be primary requirements. In view of the current surge of.

Original language	English (US)
Pages (from-to)	267-269
Number of pages	3
Journal	New England Journal of Medicine
Volume	301
Issue number	5
DOIs	https://doi.org/10.1056/NEJM197908023010511
State	Published - Aug 2 1979

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJM197908023010511

Cite this

@article{01c37038b1844a5cb5a171a1c43550c2,

title = "Infusion-Pump Treatment of Diabetes Mellitus",

abstract = "To the Editor: The report by Dr. Tamborlane and his colleagues1 confirmed our preliminary results2 3 4 on short-term, continuous, subcutaneous insulin infusion (CSII) in insulin-dependent diabetics. The portable Auto Syringe that they used clearly has a more flexible rate adjustment than our earlier model had, but this versatility can only be bought at a price that we considered excessive. The drawbacks are the weight and bulk of the device and, of equal importance, the liability to ill advised tinkering and tampering with infusion rates. Simplicity and reliability seem to us to be primary requirements. In view of the current surge of.",

author = "John Pickup and Giancarlo Viberti and Harry Keen and John Parsons and George Alberti and Service, {F. J.} and Rizza, {R. A.} and Gerich, {J. E.} and Tattersall, {Robert B.} and Gale, {Edwin A.M.} and Philip Felig and William Tamborlane and Sherwin, {Robert S.} and Myron Genel",

year = "1979",

month = aug,

day = "2",

doi = "10.1056/NEJM197908023010511",

language = "English (US)",

volume = "301",

pages = "267--269",

journal = "New England Journal of Medicine",

issn = "1533-4406",

publisher = "Massachussetts Medical Society",

number = "5",

}

TY - JOUR

T1 - Infusion-Pump Treatment of Diabetes Mellitus

AU - Pickup, John

AU - Viberti, Giancarlo

AU - Keen, Harry

AU - Parsons, John

AU - Alberti, George

AU - Service, F. J.

AU - Rizza, R. A.

AU - Gerich, J. E.

AU - Tattersall, Robert B.

AU - Gale, Edwin A.M.

AU - Felig, Philip

AU - Tamborlane, William

AU - Sherwin, Robert S.

AU - Genel, Myron

PY - 1979/8/2

Y1 - 1979/8/2

N2 - To the Editor: The report by Dr. Tamborlane and his colleagues1 confirmed our preliminary results2 3 4 on short-term, continuous, subcutaneous insulin infusion (CSII) in insulin-dependent diabetics. The portable Auto Syringe that they used clearly has a more flexible rate adjustment than our earlier model had, but this versatility can only be bought at a price that we considered excessive. The drawbacks are the weight and bulk of the device and, of equal importance, the liability to ill advised tinkering and tampering with infusion rates. Simplicity and reliability seem to us to be primary requirements. In view of the current surge of.

AB - To the Editor: The report by Dr. Tamborlane and his colleagues1 confirmed our preliminary results2 3 4 on short-term, continuous, subcutaneous insulin infusion (CSII) in insulin-dependent diabetics. The portable Auto Syringe that they used clearly has a more flexible rate adjustment than our earlier model had, but this versatility can only be bought at a price that we considered excessive. The drawbacks are the weight and bulk of the device and, of equal importance, the liability to ill advised tinkering and tampering with infusion rates. Simplicity and reliability seem to us to be primary requirements. In view of the current surge of.

UR - http://www.scopus.com/inward/record.url?scp=0018780124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018780124&partnerID=8YFLogxK

U2 - 10.1056/NEJM197908023010511

DO - 10.1056/NEJM197908023010511

M3 - Letter

C2 - 449995

AN - SCOPUS:0018780124

SN - 1533-4406

VL - 301

SP - 267

EP - 269

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 5

ER -

Infusion-Pump Treatment of Diabetes Mellitus

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this